Summary: Quotient Sciences now offers FreeThink Technologies, Inc.’s ASAPprime® software as an add-on service to drug programs, enabling rapid prediction of long-term product shelf-life. Dr. Helen Baker, Director of Formulation Design at Quotient Sciences, explains how the FreeThink Technologies, Inc.’s ASAPprime® software accelerates stability testing.
Traditional drug development stability studies are known to be demanding in terms of both time and resources. Accelerating testing using the Arrhenius equation and complex modeling to predict chemical degradation by analyzing samples stored under “stressed” conditions can greatly reduce the time required to generate the same data.
Quotient Sciences now offers FreeThink Technologies, Inc.’s ASAPprime® software as an add-on service to drug programs to rapidly predict long-term product shelf-life.
FreeThink Technologies, Inc.’s ASAPprime® software can accelerate data-driven decision-making at all stages of the drug development process by fast-tracking excipient compatibility and prototype selection in early development, packaging stability and shelf life, and excipient or API change assessment in commercial products.
A dedicated stability lab to support programs and products utilizing this software has been set up at Quotient Sciences laboratories with full compatibility for both in-house testing and cross-site collaboration.
We’re pleased to offer this service as part of our ongoing commitment to cutting-edge science and accelerating molecules to market. Contact us today for more information about how we can help you leverage ASAPprime® software in your drug program.
Note: Our accelerated stability assessment services utilize the ASAPprime® stability assessment software licensed from FreeThink Technologies, Inc.